A Study on the Incidence And Prevalence of Cardiovascular Morbidity And Mortality In Patients Undergoing Maintenance Hemodialysis

Year : 2024 | Volume : | : | Page : –
By
vector

Iqtisam Mushtaq Bhat,

vector

Ibtisam Nazir Khan,

vector

Pankaj Kaul,

  1. Assistant Professor, Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India
  2. , Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India
  3. Dean, Department of Allied & Health Sciences, Rayat Bahra University, Mohali, Punjab, India

Abstract document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_121582’);});Edit Abstract & Keyword

Cardiovascular Disease (CVD) is a major complication for patients with end-stage renal disease (ESRD) on Haemodialysis (HD), with the mortality rate from CVD being nearly 20 times higher than in the general population. As Chronic Kidney Disease (CKD) advances, patients accumulate both traditional and kidney-specific cardiovascular risk factors, such as hypertension, diabetes, fluid overload, electrolyte imbalances, and uremic toxins. These factors contribute significantly to the increased cardiovascular morbidity and mortality in this group. This study aimed to assess the incidence, prevalence, and variety of cardiovascular manifestations among CKD patients receiving maintenance haemodialysis (MHD) and to identify key risk factors for cardiovascular events in this population. A cross-sectional observational study was conducted with 50 CKD patients on MHD, with data collected through personal interviews using a structured questionnaire. The questionnaire included various parameters associated with cardiovascular outcomes in this group. Key assessments involved Electrocardiography (ECG), 2D Echocardiography, Stress Thallium Test, Stress Echocardiography, and Treadmill Test (TMT). Results indicated a high prevalence of hypertension and diabetes among the participants. Cardiovascular manifestations were common and diverse within the cohort, indicating a significant cardiovascular burden among patients undergoing MHD. CKD patients on MHD showed a high prevalence of CVD, with hypertension and diabetes as prominent risk factors. These findings underscore the importance of thorough cardiovascular evaluation and management for improving outcomes and reducing cardiovascular events in this high-risk population.

Keywords: Cardiovascular Disease, End-Stage Renal Disease, Haemodialysis, Chronic Kidney Disease, Hypertension, Diabetes, Cardiovascular Risk Factors, Electrocardiography, Echocardiography, Stress Testing, Cardiovascular Morbidity.

How to cite this article:
Iqtisam Mushtaq Bhat, Ibtisam Nazir Khan, Pankaj Kaul. A Study on the Incidence And Prevalence of Cardiovascular Morbidity And Mortality In Patients Undergoing Maintenance Hemodialysis. Research & Reviews : A Journal of Life Sciences. 2024; ():-.
How to cite this URL:
Iqtisam Mushtaq Bhat, Ibtisam Nazir Khan, Pankaj Kaul. A Study on the Incidence And Prevalence of Cardiovascular Morbidity And Mortality In Patients Undergoing Maintenance Hemodialysis. Research & Reviews : A Journal of Life Sciences. 2024; ():-. Available from: https://journals.stmjournals.com/rrjols/article=2024/view=0

Full Text PDF

Full Text PDF

References
document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_121582’);});Edit

  1. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. Journal of the American Society of Nephrology: JASN. 1998 Dec 1;9(12 Suppl):S16-23.
  2. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: a cross-sectional study. Journal of the American Society of Nephrology. 2001 Jul 1;12(7):1516-23.
  3. Foley RN, Parfrey PS. Cardiac disease in chronic uremia: clinical outcome and risk factors. Advances in renal replacement therapy. 1997 Jul 1;4(3):234-48.
  4. heung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, Lewis J, Rocco M, Toto R, Windus D, Ornt D. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney international. 2004 Jun 1;65(6):2380-9.
  5. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, Peter WS, Guo H. US renal data system 2011 annual data report. American journal of kidney diseases. 2012 Jan 1;59(1):A7.
  6. Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, Okpechi IG, Salako BL, Wiebe N, Ye F, Tonelli M. Global kidney health atlas (GKHA): design and methods. Kidney international supplements. 2017 Oct 1;7(2):145-53.
  7. Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B. Assessment of global kidney health care status. Jama. 2017 May 9;317(18):1864-81.
  8. Locatelli F, Pozzoni P, Del Vecchio L. Renal replacement therapy in patients with diabetes and end-stage renal disease. Journal of the American Society of Nephrology. 2004 Jan 1;15(1_suppl):S25-9.
  9. Le Feuvre C, Borentain M, Beygui F, Helft G, Batisse JP, Metzger JP. Comparison of short-and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis. The American journal of cardiology. 2003 Sep 15;92(6):721-5..
  10. Trespalacios FC, Taylor AJ, Agodoa LY, Abbott KC. Incident acute coronary syndromes in chronic dialysis patients in the United States. Kidney international. 2002 Nov 1;62(5):1799-805.
  11. Metra M, Cannella G, La Canna G, Guaini T, Sandrini M, Gaggiotti M, Movilli E, Dei Cas L. Improvement in exercise capacity after correction of anemia in patients with end-stage renal failure. The American journal of cardiology. 1991 Oct 15;68(10):1060-6.
  12. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. New England Journal of Medicine. 1994 Mar 31;330(13):877-84.
  13. Buckalew Jr VM, Berg RL, Wang SR, Porush JG, Sally R, Schulman G, Modification of Diet in Renal Disease Study Group. Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. American Journal of Kidney Diseases. 1996 Dec 1;28(6):811-21.
  14. Rocco MV, Flanigan MJ, Beaver S, Frederick P, Gentile DE, McClellan WM, Polder J, Prowant BF, Taylor L, Helgerson SD. Report from the 1995 core indicators for peritoneal dialysis study group. American journal of kidney diseases. 1997 Aug 1;30(2):165-73..
  15. Fishbane S, Natke E, Maesaka JK. Role of volume overload in dialysis-refractory hypertension. American journal of kidney diseases. 1996 Aug 1;28(2):257-61.
  16. Venkatesan J, Henrich WL. Anemia, hypertension, and myocardial dysfunction in end-stage renal disease. InSeminars in nephrology 1997 Jul 1 (Vol. 17, No. 4, pp. 257-269).
  17. Silberberg JS, Rahal DP, Patton DR, Sniderman AD. Role of anemia in the pathogenesis of left ventricular hypertrophy in end-stage renal disease. The American journal of cardiology. 1989 Jul 15;64(3):222-4.
  18. Macdougall IC, Coles GA, Williams JD, Davies ME, Hutton RD, Cochlin DL, Lewis NP, Fox KA, Saunders MJ. Long-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietin. The Lancet. 1990 Mar 3;335(8688):489-93.
Ahead of Print Subscription Original Research
Volume
Received 08/10/2024
Accepted 18/11/2024
Published 26/11/2024
283